Sign In
Buy AERI
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Healthcare Pro James Flynn Picks up These 3 Stocks on the Cheap
02:15pm, Wednesday, 25'th Mar 2020
And just like that, stocks have landed back in the green. Following a several week long market performance that can only be described as tumultuous, the
Aerie Pharmaceuticals (NASDAQ:AERI) PT Lowered to $17.00
09:06am, Wednesday, 25'th Mar 2020
Aerie Pharmaceuticals (NASDAQ:AERI) had its price target reduced by equities research analysts at Bank of America from $26.00 to $17.00 in a research report issued to clients and investors on Monday,
Bank of America Reiterates Hold Rating for Aerie Pharmaceuticals (NASDAQ:AERI)
05:44am, Wednesday, 25'th Mar 2020
Aerie Pharmaceuticals (NASDAQ:AERI)‘s stock had its “hold” rating reiterated by equities research analysts at Bank of America in a research note issued to investors on Monday, AnalystRatings.com
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
Wall Street Analysts Are Bullish on Top Healthcare Picks
08:19am, Tuesday, 24'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma (AERI) and Gilead Sciences (GILD) with bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
08:19am, Tuesday, 24'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aerie Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 23.)
Arcutis Biotherapeutics...
Stocks That Hit 52-Week Lows On Monday
02:34pm, Monday, 23'rd Mar 2020
On Monday morning, 720 companies hit new 52-week lows.
Noteworthy Mentions:
The largest company by market cap to set a new 52-week low was Alphabet (NASDAQ: GOOGL)...
Merrill Lynch Maintains a Hold Rating on Aerie Pharma (AERI)
02:20pm, Monday, 23'rd Mar 2020
In a report released today, Jason Gerberry from Merrill Lynch maintained a Hold rating on Aerie Pharma (AERI), with a price target of $17.00. The
Merrill Lynch Maintains a Hold Rating on Aerie Pharma (AERI)
02:20pm, Monday, 23'rd Mar 2020
In a report released today,
Jason Gerberry
from Merrill Lynch maintained a
Hold
rating on Aerie Pharma (
AERI
–
Research Report
), with a price target of
$17.00
. The company’s shares closed last
Financial Contrast: Aerie Pharmaceuticals (NASDAQ:AERI) and BioCryst Pharmaceuticals (NASDAQ:BCRX)
08:26am, Monday, 23'rd Mar 2020
Aerie Pharmaceuticals (NASDAQ:AERI) and BioCryst Pharmaceuticals (NASDAQ:BCRX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the
B of A Securities Maintains Neutral on Aerie Pharmaceuticals, Lowers Price Target to $17
12:00am, Monday, 23'rd Mar 2020Why Is Aerie (AERI) Down 40.5% Since Last Earnings Report?
03:30pm, Saturday, 21'st Mar 2020
Aerie (AERI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Aerie (AERI) Down 40.5% Since Last Earnings Report?
03:30pm, Saturday, 21'st Mar 2020
Aerie (AERI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
